APA

Holleboom A. G., Karlsson H., Lin R., Beres T. M., Sierts J. A., Herman D. S., Stroes E. S. G., Aerts J. M., Kastelein J. J. P., Motazacker M. M., Dallinga-Thie G. M., Levels J. H. M., Zwinderman A. H., Seidman J. G., Seidman C. E., Ljunggren S., Lefeber D. J., Morava E., Wevers R. A., Fritz T. A., Tabak L. A., Lindahl M., Hovingh G. K. & Kuivenhoven J. A. (20120416). Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. : Cell metabolism.

Chicago

Holleboom Adriaan G, Karlsson Helen, Lin Ruei-Shiuan, Beres Thomas M, Sierts Jeroen A, Herman Daniel S, Stroes Erik S G, Aerts Johannes M, Kastelein John J P, Motazacker Mohammad M, Dallinga-Thie Geesje M, Levels Johannes H M, Zwinderman Aeilko H, Seidman Jonathan G, Seidman Christine E, Ljunggren Stefan, Lefeber Dirk J, Morava Eva, Wevers Ron A, Fritz Timothy A, Tabak Lawrence A, Lindahl Mats, Hovingh G Kees and Kuivenhoven Jan Albert. 20120416. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. : Cell metabolism.

Harvard

Holleboom A. G., Karlsson H., Lin R., Beres T. M., Sierts J. A., Herman D. S., Stroes E. S. G., Aerts J. M., Kastelein J. J. P., Motazacker M. M., Dallinga-Thie G. M., Levels J. H. M., Zwinderman A. H., Seidman J. G., Seidman C. E., Ljunggren S., Lefeber D. J., Morava E., Wevers R. A., Fritz T. A., Tabak L. A., Lindahl M., Hovingh G. K. and Kuivenhoven J. A. (20120416). Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. : Cell metabolism.

MLA

Holleboom Adriaan G, Karlsson Helen, Lin Ruei-Shiuan, Beres Thomas M, Sierts Jeroen A, Herman Daniel S, Stroes Erik S G, Aerts Johannes M, Kastelein John J P, Motazacker Mohammad M, Dallinga-Thie Geesje M, Levels Johannes H M, Zwinderman Aeilko H, Seidman Jonathan G, Seidman Christine E, Ljunggren Stefan, Lefeber Dirk J, Morava Eva, Wevers Ron A, Fritz Timothy A, Tabak Lawrence A, Lindahl Mats, Hovingh G Kees and Kuivenhoven Jan Albert. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. : Cell metabolism. 20120416.